The importance of pets as reservoirs of resistant Enterococcus strains, with special reference to vancomycin

Journal of Veterinary Medicine, Series B

Volumn 49, Issue 6, 2002, Pages 278-280

  Rodrigues, J ^a,b   Poeta, P ^a   Martins, A ^a   Costa, D ^a  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b NONE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFOPERAZONE; ERYTHROMYCIN; NALIDIXIC ACID; OXACILLIN;

ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; CAT; CLASSIFICATION; DISEASE CARRIER; DOG; DRUG EFFECT; ENTEROCOCCUS; FECES; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHENOTYPE;

ANIMALS; ANTI-BACTERIAL AGENTS; CATS; CEFOPERAZONE; DISEASE RESERVOIRS; DOGS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; ERYTHROMYCIN; FECES; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; OXACILLIN; PHENOTYPE; VANCOMYCIN RESISTANCE;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; ENTEROCOCCUS; ENTEROCOCCUS AVIUM; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FELIS CATUS;

EID: 0036689381     PISSN: 09311793     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0450.2002.00561.x     Document Type: Article

References (18)

1. Characters of Gram-positive bacteria
2. Farm animals as putative reservoirs for vancomycin-resistant enterococcal infections in man
3. Streptococci
4. Enterococci and vancomycin resistance
5. Multiple-drug resistant Enterococci: The nature of the problem and an agenda for the future
6. Epidemiology and ecology of enterococci, with special reference to antibiotic resistant strains, in animals, humans and the environment. Example of an ongoing project within the European research programme
7. Characterization of glycopeptide-resistant Enterococci from a Swiss hospital
8. Emerging problems with enterococcal infections
9. Identification of Enterococcus spp. with a biochemical key
10. Vancomycin-resistant Enterococci outside the health-care setting. Prevalence, sources and public health implications
11. Enterococcal infections in patients treated with moxalactam, a new broad-spectrum antibiotic
12. Emergence of vancomicyn-resistant enterococci
13. Epidemiologic evaluation of antimicrobial resistance in community-acquired Enterococci
14. Implications of vancomycin-resistant Staphyloccus aureus
15. Current perspectives on glycopeptide resistance